Oncolytics BiotechONCY

13F holders, Q2 2024 (June 30)
41holders +5
9new positions
4sold out
1famous investor
$0.99avg. 13F price*

At the end of Q2 2024, 41 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings, up 5 from Q1 2024. 9 opened new positions and 4 sold out. The largest holders were International Assets Investment Management, LLC ($196K), Seeds Investor LLC ($188K) and Morgan Stanley ($137K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Oncolytics Biotech Inc.
CUSIP
682310875
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 36Q1 2024Q2 2024: 41Q2 2024Q3 2024: 42Q3 2024Q4 2024: 46Q4 2024Q1 2025: 51Q1 2025Q2 2025: 55Q2 2025Q3 2025: 56Q3 2025Q4 2025: 61Q4 2025Q1 2026: 57Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions9$214K
Exits4$79K

All 13F filers, Q1 2024 → Q2 2024: 245,572 shares bought and 348,588 shares sold, net −103,016 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 41 holders

International Assets Investment Management, LLC 0.02% Reduce -1.5% 198,400 $196K
Seeds Investor LLC 0.10% New 189,941 $188K
Morgan Stanley 0.00% Reduce -60.2% 138,521 $137K
Citadel Advisors 0.00% Reduce -15.8% 137,085 $136K
Goldman Sachs Group Inc. 0.00% No change 83,598 $83K
Commonwealth Equity Services, LLC 0.00% Add +0.6% 63,114 $62K
Royal Bank of Canada 0.00% Add +2.0% 62,267 $62K
Cibc World Market Inc. 0.00% Reduce -0.5% 57,835 $57K
Geode Capital Management, LLC 0.00% No change 41,942 $42K
Long Focus Capital Management, LLC 0.00% No change 40,000 $40K
Bank of Montreal 0.00% Add +0.3% 37,425 $39K
Virtu Financial LLC 0.00% Reduce -47.1% 27,442 $27K
Brave Asset Management Inc. 0.01% No change 25,000 $25K
National Bank of Canada 0.00% Add +85.5% 21,697 $21K
Ausdal Financial Partners, Inc. 0.00% Reduce -19.2% 21,000 $21K
LPL Financial LLC 0.00% Add +13.9% 20,509 $20K
Headinvest, LLC 0.00% Add +5.4% 17,434 $17K
C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors 0.00% No change 15,000 $15K
Federation des caisses Desjardins du Quebec 0.00% Add +303.6% 13,294 $13K
Jane Street Group, LLC 0.00% New 12,728 $13K
Banque Cantonale Vaudoise 0.00% No change 11,900 $12K
Kingsview Wealth Management, LLC 0.00% No change 11,000 $11K
PFG Investments, LLC 0.00% No change 10,500 $10K
Professional Advisory Services Inc. 0.00% No change 10,000 $10K
Osaic Holdings, Inc. 0.00% Reduce -36.3% 8,497 $8K
Cedar Mountain Advisors, LLC 0.00% No change 5,651 $6K
UBS Group AG 0.00% Add +381.4% 5,603 $6K
Activest Wealth Management 0.00% New 5,000 $5K
Wells Fargo & Company 0.00% No change 4,401 $4K
Tower Research Capital LLC (TRC) 0.00% New 3,239 $3K
IFP Advisors, Inc 0.00% No change 2,500 $2K
Allworth Financial LP 0.00% New 2,000 $2K
BNP Paribas Financial Markets 0.00% New 1,900 $2K
Cwm, LLC 0.00% Reduce -43.0% 1,325 $1K
TD Waterhouse Canada Inc. 0.00% New 662 $660
Toronto Dominion Bank 0.00% New 474 $469
JNBA Financial Advisors 0.00% No change 210 $208
Pacifica Partners Inc. 0.00% New 100 $101
Aviso Financial Inc. 0.00% — 56 $55
Wolff Wiese Magana LLC 0.00% No change 31 $31
1832 Asset Management L.P. 0.00% No change 5 $5

"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.